{"id":14723,"date":"2019-03-29T11:54:00","date_gmt":"2019-03-29T10:54:00","guid":{"rendered":"https:\/\/www.gsk.de\/?p=14723"},"modified":"2021-09-08T12:55:48","modified_gmt":"2021-09-08T10:55:48","slug":"gesetzgebungsverfahren-werfen-ihre-schatten-voraus-2","status":"publish","type":"post","link":"https:\/\/gsk.de\/de\/gesetzgebungsverfahren-werfen-ihre-schatten-voraus-2\/","title":{"rendered":"Gesetzgebungsverfahren werfen ihre Schatten voraus"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">\u00dcberarbeitung der AIFM-Richtlinie und Solvency II wie auch ESG und grenz\u00fcberschreitender Fondsvertrieb lassen der PE- und VC-Fonds keine Regulierungspause. Untenstehend finden Sie den Artikel als Download.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Arne Bolch, GSK Luxembourg SA, und Anja Grenner, Intertrust Luxembourg S.\u00e0.r.l., B\u00f6rsen-Zeitung, 27.03.2019.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00dcberarbeitung der AIFM-Richtlinie und Solvency II wie auch ESG und grenz\u00fcberschreitender Fondsvertrieb lassen der PE- und VC-Fonds keine Regulierungspause. Untenstehend finden Sie den Artikel als Download. Arne Bolch, GSK Luxembourg SA, und Anja Grenner, Intertrust Luxembourg S.\u00e0.r.l., B\u00f6rsen-Zeitung, 27.03.2019.<\/p>\n","protected":false},"author":32,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[282],"tags":[],"ausgabe":[670],"verknuepfung":[],"class_list":["post-14723","post","type-post","status-publish","format-standard","hentry","category-pressespiegel","ausgabe-gsk-luxemburg"],"acf":{"ansprechpartner":false,"postdownloads":[{"download":"https:\/\/gsk.de\/wp-content\/uploads\/2020\/01\/2019-03-27_BZ__Gesetzgebungsverfahren.pdf","anzeigetitel":""}]},"info":{"date":"29.03.2019","author":"GSK Sysop","categories_names":["Pressespiegel"],"category":"Pressespiegel"},"wpml_main_post_id":14723,"featured_img_src":"","_links":{"self":[{"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/posts\/14723","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/comments?post=14723"}],"version-history":[{"count":0,"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/posts\/14723\/revisions"}],"wp:attachment":[{"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/media?parent=14723"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/categories?post=14723"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/tags?post=14723"},{"taxonomy":"ausgabe","embeddable":true,"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/ausgabe?post=14723"},{"taxonomy":"verknuepfung","embeddable":true,"href":"https:\/\/gsk.de\/de\/wp-json\/wp\/v2\/verknuepfung?post=14723"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}